DK0919619T4 - Optimering af celler til endogen genaktivering - Google Patents

Optimering af celler til endogen genaktivering

Info

Publication number
DK0919619T4
DK0919619T4 DK98122807.5T DK98122807T DK0919619T4 DK 0919619 T4 DK0919619 T4 DK 0919619T4 DK 98122807 T DK98122807 T DK 98122807T DK 0919619 T4 DK0919619 T4 DK 0919619T4
Authority
DK
Denmark
Prior art keywords
optimization
cells
endogenous gene
gene activation
activation
Prior art date
Application number
DK98122807.5T
Other languages
English (en)
Other versions
DK0919619T3 (da
Inventor
Konrad Honold
Thomas Holtschke
Anne Stern
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227717&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0919619(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0919619T3 publication Critical patent/DK0919619T3/da
Publication of DK0919619T4 publication Critical patent/DK0919619T4/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/505Erythropoietin [EPO]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
DK98122807.5T 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering DK0919619T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97121075 1997-12-01

Publications (2)

Publication Number Publication Date
DK0919619T3 DK0919619T3 (da) 2006-07-10
DK0919619T4 true DK0919619T4 (da) 2013-09-23

Family

ID=8227717

Family Applications (3)

Application Number Title Priority Date Filing Date
DK98122807.5T DK0919619T4 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering
DK99112607T DK0957165T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering
DK04006966T DK1464705T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK99112607T DK0957165T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering
DK04006966T DK1464705T3 (da) 1997-12-01 1998-12-01 Optimering af celler til endogen genaktivering

Country Status (16)

Country Link
US (1) US7008764B1 (da)
EP (3) EP0957165B1 (da)
JP (1) JP4629813B2 (da)
KR (1) KR100367062B1 (da)
CN (2) CN1232644C (da)
AR (4) AR018022A1 (da)
AT (3) ATE318904T1 (da)
AU (1) AU757930B2 (da)
BR (1) BR9805682A (da)
CA (1) CA2252970C (da)
DE (3) DE59813976D1 (da)
DK (3) DK0919619T4 (da)
ES (3) ES2259422T3 (da)
PT (3) PT957165E (da)
TR (1) TR199802503A3 (da)
ZA (1) ZA9810915B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2278021A3 (en) * 1999-11-01 2011-05-18 Novartis Vaccines and Diagnostics, Inc. Expression vectors, transfection systems, and method of use thereof
CA2401677A1 (en) * 2000-03-03 2001-09-13 University Of Utah Research Foundation Gene targeting method
DE10023887A1 (de) * 2000-05-17 2001-11-29 Axel Haverich Verfahren zur transienten Insertion genetischer Elemente
ATE375388T1 (de) 2001-07-27 2007-10-15 Us Gov Health & Human Serv Systeme zur stellengerichteten in-vivo-mutagenese mit oligonukleotiden
CA2474486C (en) 2002-01-23 2013-05-14 The University Of Utah Research Foundation Targeted chromosomal mutagenesis using zinc finger nucleases
EP2806025B1 (en) 2002-09-05 2019-04-03 California Institute of Technology Use of zinc finger nucleases to stimulate gene targeting
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US20120196370A1 (en) 2010-12-03 2012-08-02 Fyodor Urnov Methods and compositions for targeted genomic deletion
US11311574B2 (en) 2003-08-08 2022-04-26 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
CA2579677A1 (en) * 2004-09-16 2006-03-30 Sangamo Biosciences, Inc. Compositions and methods for protein production
KR101419729B1 (ko) * 2005-07-26 2014-07-17 상가모 바이오사이언스 인코포레이티드 외래 핵산 서열의 표적화된 통합 및 발현
CN103484496A (zh) * 2013-07-31 2014-01-01 新乡医学院 一种报告基因重组在染色体目的基因上的方法、位点及用途
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
WO2016100049A1 (en) 2014-12-18 2016-06-23 Edico Genome Corporation Chemically-sensitive field effect transistor
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
EP3459115A4 (en) 2016-05-16 2020-04-08 Agilome, Inc. GRAPHEN-FET DEVICES, SYSTEMS AND METHODS FOR USE THEREOF FOR SEQUENCING NUCLEIC ACIDS

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US568772A (en) * 1896-10-06 Albert s
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
GB2187415A (en) 1986-03-05 1987-09-09 Deere & Co Machine for forming cylindrical bales of crop
JPS62265992A (ja) * 1986-05-12 1987-11-18 Ajinomoto Co Inc ヒト細胞を用いる有用物質の製造方法
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
FR2646438B1 (fr) * 1989-03-20 2007-11-02 Pasteur Institut Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
EP0747485B1 (en) * 1989-11-06 1998-12-02 Cell Genesys, Inc. Production of proteins using homologous recombination
JP3501286B2 (ja) * 1989-12-22 2004-03-02 アプライド リサーチ システムズ,エーアールエス ホールディング ナームロゼ ベノートスハップ 一定の細胞系又は微生物の内因性遺伝子の発現特徴の変性のための方法
US5272071A (en) * 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
WO1992015694A1 (en) * 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
WO1993015191A1 (en) * 1992-01-24 1993-08-05 Life Technologies, Inc. Modulation of enzyme activities in the in vivo cloning of dna
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5527695A (en) 1993-01-29 1996-06-18 Purdue Research Foundation Controlled modification of eukaryotic genomes
JP3654446B2 (ja) * 1993-12-23 2005-06-02 メルク アンド カンパニー, インコーポレイテッド マウス細胞のための相同的組換え抗体発現系
US6130364A (en) * 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US5882914A (en) 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
US5695977A (en) * 1995-08-31 1997-12-09 Genetic Information Research Institute Site directed recombination
AUPN903196A0 (en) * 1996-03-29 1996-04-26 Australian National University, The Single-step excision means
US6020144A (en) * 1996-09-12 2000-02-01 Symbiontics, Inc. Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same

Also Published As

Publication number Publication date
DE59813413D1 (de) 2006-04-27
EP0919619A2 (de) 1999-06-02
EP0957165B1 (de) 2007-04-18
AU9328498A (en) 1999-06-17
EP0919619A3 (de) 1999-07-21
PT1464705E (pt) 2006-08-31
ES2258809T5 (es) 2013-09-05
KR100367062B1 (ko) 2004-05-31
CN1590551A (zh) 2005-03-09
EP1464705A1 (de) 2004-10-06
EP1464705B1 (de) 2006-03-15
AR020893A2 (es) 2002-06-05
PT957165E (pt) 2007-07-19
ES2259422T3 (es) 2006-10-01
ES2258809T3 (es) 2006-09-01
CN1240829A (zh) 2000-01-12
ZA9810915B (en) 2000-05-30
TR199802503A2 (xx) 1999-06-21
BR9805682A (pt) 2000-04-11
JPH11225785A (ja) 1999-08-24
DK1464705T3 (da) 2006-07-24
CN100519751C (zh) 2009-07-29
CA2252970C (en) 2011-11-15
EP0957165A3 (de) 2000-10-04
PT919619E (pt) 2006-07-31
AR020750A2 (es) 2002-05-29
US7008764B1 (en) 2006-03-07
DK0957165T3 (da) 2007-07-30
ATE360067T1 (de) 2007-05-15
DE59813976D1 (de) 2007-05-31
CN1232644C (zh) 2005-12-21
AR020892A2 (es) 2002-06-05
DE59813438D1 (de) 2006-05-11
ES2284228T3 (es) 2007-11-01
DK0919619T3 (da) 2006-07-10
KR19990062655A (ko) 1999-07-26
JP4629813B2 (ja) 2011-02-09
CA2252970A1 (en) 1999-06-01
AR018022A1 (es) 2001-10-31
EP0919619B2 (de) 2013-06-19
EP0957165A2 (de) 1999-11-17
ATE320491T1 (de) 2006-04-15
AU757930B2 (en) 2003-03-13
ATE318904T1 (de) 2006-03-15
EP0919619B1 (de) 2006-03-01
TR199802503A3 (tr) 1999-06-21

Similar Documents

Publication Publication Date Title
DK1464705T3 (da) Optimering af celler til endogen genaktivering
ID19961A (id) Sel jenis tipis
DE69824784D1 (de) Brennstoffzelle
DE69831948D1 (de) Selbständiges zellwachstumssystem
ID24612A (id) Hidrogenolisis gliserol
DK1005517T3 (da) Fremgangsmåde til fremstilling af diglycerider
DE69832046D1 (de) Elektrolytische feststoffzelle
DE69839754D1 (de) Kurzzellenmultiplexer
DE69841343D1 (de) Festelektrolytzelle
DE59803169D1 (de) Bearbeitungszelle
DE69826125D1 (de) Fixiergerät
DE69835919D1 (de) Programmaufbauunterstützungssystem
DE69825282D1 (de) Unterstützungsystem
DE69825647D1 (de) Befestigungssytem
DE69813680D1 (de) Gruppenantenne unter Verwendung von Verzögerungsleitungen
DE69835316D1 (de) Festelektrolyt
DK0927766T3 (da) Enzymatisk fremgangsmåde til fremstilling af (S)-cyanhydriner
DK2281892T3 (da) Fremgangsmåde til fremstilling af respiratorisk-deficiente Trichoderma-celler
DK0951561T3 (da) Enzymatiske fremgangsmåder til fremstilling af (S)-cyanhydriner
DE69825927D1 (de) Fixiereinrichtung
DE29717428U1 (de) Zwischensohlen-Struktur
IT1291111B1 (it) Ubiquitina-isopeptidasi di mammifero che controllano la proliferazione cellulare
DE69838302D1 (de) Gruppenlaufzeitentzerrer
NO20002816D0 (no) Byggebjelke
DE29710244U1 (de) Raumschiff